187 related articles for article (PubMed ID: 21357833)
1. POLG1 manifestations in childhood.
Isohanni P; Hakonen AH; Euro L; Paetau I; Linnankivi T; Liukkonen E; Wallden T; Luostarinen L; Valanne L; Paetau A; Uusimaa J; Lönnqvist T; Suomalainen A; Pihko H
Neurology; 2011 Mar; 76(9):811-5. PubMed ID: 21357833
[TBL] [Abstract][Full Text] [Related]
2. POLG1 mutations associated with progressive encephalopathy in childhood.
Kollberg G; Moslemi AR; Darin N; Nennesmo I; Bjarnadottir I; Uvebrant P; Holme E; Melberg A; Tulinius M; Oldfors A
J Neuropathol Exp Neurol; 2006 Aug; 65(8):758-68. PubMed ID: 16896309
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and genotypic variability in Alpers syndrome.
Sofou K; Moslemi AR; Kollberg G; Bjarnadóttir I; Oldfors A; Nennesmo I; Holme E; Tulinius M; Darin N
Eur J Paediatr Neurol; 2012 Jul; 16(4):379-89. PubMed ID: 22237560
[TBL] [Abstract][Full Text] [Related]
4. Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus.
Uusimaa J; Hinttala R; Rantala H; Päivärinta M; Herva R; Röyttä M; Soini H; Moilanen JS; Remes AM; Hassinen IE; Majamaa K
Epilepsia; 2008 Jun; 49(6):1038-45. PubMed ID: 18294203
[TBL] [Abstract][Full Text] [Related]
5. Alpers syndrome with mutations in POLG: clinical and investigative features.
Hunter MF; Peters H; Salemi R; Thorburn D; Mackay MT
Pediatr Neurol; 2011 Nov; 45(5):311-8. PubMed ID: 22000311
[TBL] [Abstract][Full Text] [Related]
6. Molecular diagnosis of Alpers syndrome.
Nguyen KV; Sharief FS; Chan SS; Copeland WC; Naviaux RK
J Hepatol; 2006 Jul; 45(1):108-16. PubMed ID: 16545482
[TBL] [Abstract][Full Text] [Related]
7. Status epilepticus in children with Alpers' disease caused by POLG1 mutations: EEG and MRI features.
Wolf NI; Rahman S; Schmitt B; Taanman JW; Duncan AJ; Harting I; Wohlrab G; Ebinger F; Rating D; Bast T
Epilepsia; 2009 Jun; 50(6):1596-607. PubMed ID: 19054397
[TBL] [Abstract][Full Text] [Related]
8. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion.
Naviaux RK; Nguyen KV
Ann Neurol; 2004 May; 55(5):706-12. PubMed ID: 15122711
[TBL] [Abstract][Full Text] [Related]
9. Compound heterozygous polymerase gamma gene mutation in a patient with Alpers disease.
Cardenas JF; Amato RS
Semin Pediatr Neurol; 2010 Mar; 17(1):62-4. PubMed ID: 20434700
[TBL] [Abstract][Full Text] [Related]
10. POLG mutations and Alpers syndrome.
Davidzon G; Mancuso M; Ferraris S; Quinzii C; Hirano M; Peters HL; Kirby D; Thorburn DR; DiMauro S
Ann Neurol; 2005 Jun; 57(6):921-3. PubMed ID: 15929042
[TBL] [Abstract][Full Text] [Related]
11. Alpers syndrome with prominent white matter changes.
Bao X; Wu Y; Wong LJ; Zhang Y; Xiong H; Chou PC; Truong CK; Jiang Y; Qin J; Yuan Y; Lin Q; Wu X
Brain Dev; 2008 Apr; 30(4):295-300. PubMed ID: 17923349
[TBL] [Abstract][Full Text] [Related]
12. Juvenile Alpers disease.
Wiltshire E; Davidzon G; DiMauro S; Akman HO; Sadleir L; Haas L; Zuccollo J; McEwen A; Thorburn DR
Arch Neurol; 2008 Jan; 65(1):121-4. PubMed ID: 18195149
[TBL] [Abstract][Full Text] [Related]
13. Partial status epilepticus - rapid genetic diagnosis of Alpers' disease.
McCoy B; Owens C; Howley R; Ryan S; King M; Farrell MA; Lynch BJ
Eur J Paediatr Neurol; 2011 Nov; 15(6):558-62. PubMed ID: 21704543
[TBL] [Abstract][Full Text] [Related]
14. Consequences of mutations in human DNA polymerase gamma.
Longley MJ; Graziewicz MA; Bienstock RJ; Copeland WC
Gene; 2005 Jul; 354():125-31. PubMed ID: 15913923
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene.
Horvath R; Hudson G; Ferrari G; Fütterer N; Ahola S; Lamantea E; Prokisch H; Lochmüller H; McFarland R; Ramesh V; Klopstock T; Freisinger P; Salvi F; Mayr JA; Santer R; Tesarova M; Zeman J; Udd B; Taylor RW; Turnbull D; Hanna M; Fialho D; Suomalainen A; Zeviani M; Chinnery PF
Brain; 2006 Jul; 129(Pt 7):1674-84. PubMed ID: 16621917
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial recessive ataxia syndrome mimicking dominant spinocerebellar ataxia.
Palin EJ; Hakonen AH; Korpela M; Paetau A; Suomalainen A
J Neurol Sci; 2012 Apr; 315(1-2):160-3. PubMed ID: 22166854
[TBL] [Abstract][Full Text] [Related]
17. Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase gamma (POLG1) mutations.
de Vries MC; Rodenburg RJ; Morava E; van Kaauwen EP; ter Laak H; Mullaart RA; Snoeck IN; van Hasselt PM; Harding P; van den Heuvel LP; Smeitink JA
Eur J Pediatr; 2007 Mar; 166(3):229-34. PubMed ID: 16957900
[TBL] [Abstract][Full Text] [Related]
18. Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations.
Ashley N; O'Rourke A; Smith C; Adams S; Gowda V; Zeviani M; Brown GK; Fratter C; Poulton J
Hum Mol Genet; 2008 Aug; 17(16):2496-506. PubMed ID: 18487244
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic variations in 3 children with POLG1 mutations.
Burusnukul P; de los Reyes EC
J Child Neurol; 2009 Apr; 24(4):482-6. PubMed ID: 19189930
[TBL] [Abstract][Full Text] [Related]
20. POLG mutations associated with Alpers syndrome and mitochondrial DNA depletion.
Naviaux RK; Nguyen KV
Ann Neurol; 2005 Sep; 58(3):491. PubMed ID: 16130100
[No Abstract] [Full Text] [Related]
[Next] [New Search]
